Amid a Chapter 11 restructuring, Westlake Village-based Sienna Biopharmaceuticals filed an application with regulators to take its topical silver photoparticle product to market, potentially enabling laser removal for light colored hair. The U.S. Food and Drug Administration accepted the company’s submission to commercialize its product, SNA-001, Sienna said in a news release Oct. 7. The…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
